Clinical Trial Update: Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) [NA]

View source ↗

Summary

Clinical trial update for the AROMA 1 / BIORESOURCE study evaluating volatile biomarkers for oesophagogastric cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Snippet

Sponsor: Imperial College London | Conditions: Volatile Organic Compounds, Microbiome | NA | Status: RECRUITING